引用本文:朱旭,马翼,潘昌杰.T2 mapping与T2* mapping定量值在前列腺病变中的诊断价值[J].大连医科大学学报,2021,43(5):438-441.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
T2 mapping与T2* mapping定量值在前列腺病变中的诊断价值
朱旭, 马翼, 潘昌杰
南京医科大学附属常州市第二人民医院 放射科, 江苏 常州 213100
摘要:
目的 探讨前列腺组织良恶性病变的T2 mapping与T2* mapping定量值的差异,为前列腺良恶性病变的诊断与鉴别诊断提供依据。方法 收集50例前列腺病变患者的临床资料,其中前列腺癌19例,良性前列腺病变31例,均具有手术病理或超声引导下穿刺活检病理。通过常规MRI检查及T2 mapping与T2* mapping检查,测量良恶性病灶的T2 mapping与T2* mapping定量值,分析两者之间的差异,绘制ROC曲线,确定最佳诊断临界值及其敏感性和特异性,评价诊断效能。结果 前列腺良恶性病变的T2 mapping与T2* mapping定量值差异具有统计学意义(P<0.01),其中良恶性病变的T2 mapping与T2* mapping定量值分别为(93.15±11.17)ms vs(43.21±15.39)ms和(74.50±6.93)ms vs(21.53±6.81)ms;T2mapping和T2* mapping定量值诊断的敏感性和特异性,最佳截断值,AUC,分别为68.4% vs 94.7%,96.8% vs 74.2%,77.49 ms vs 31.66 ms,0.91 vs 0.88。结论 T2 mapping与T2* mapping定量值有助于辨别前列腺良恶性的病变,是前列腺磁共振检查序列的良好补充。
关键词:  T2 mapping  T2* mapping  前列腺癌
DOI:10.11724/jdmu.2021.05.11
分类号:R44
基金项目:
Diagnostic value of quantitative T2 mapping and T2* mapping in prostatic lesions
ZHU Xu, MA Yi, PAN Changjie
Department of Radiology, Changzhou Second People's Hospital, Nanjing Medical University, Changzhou 213100, China
Abstract:
Objective To investigate the difference between quantitative values of T2 mapping and T2* mapping in benign and malignant lesions of prostate, in order to provide a basis for diagnosis and differential diagnosis of benign and malignant prostate lesions.Methods A total of 50 cases were studied,including 19 cases of prostate cancer and 31 cases of benign prostate lesions,all of which had surgical pathology or ultrasound-guided needle biopsy pathology. Routine MRI,T2 mapping and T2* mapping were performed for all patients.The quantitative values of T2 mapping and T2* mapping of benign and malignant lesions were measured and analyzed.The optimal diagnostic threshold,and its sensitivity and specificity were evaluated through ROC curve. Results There was significant difference between T2 mapping and T2* mapping in benign and malignant prostatic lesions(P<0.01).The quantitative values of T2 mapping and T2* mapping in benign and malignant lesions were(93.15±11.17)ms vs (43.21±15.39)ms and (74.50±6.93)ms vs (21.53±6.81)ms, respectively. The best cut-off values for the quantitative values of T2mapping and T2* mapping, AUC, diagnostic sensitivity and specificity were 77.49 ms vs 31.66 ms, 0.91 vs 0.88, 68.4% vs 94.7% and 96.8% vs 74.2%,respectively. Conclusion The quantitative values of T2 mapping and T2* mappingare helpful to distinguish benign and malignant prostate lesions,and are good supplement to prostate MRI sequence.
Key words:  T2 mapping  T2* mapping  prostate cancer